The prototoxin LYPD6B modulates heteromeric ?3?4-containing nicotinic acetylcholine receptors, but not ?7 homomers.
Ontology highlight
ABSTRACT: Prototoxins are a diverse family of membrane-tethered molecules expressed in the nervous system that modulate nicotinic cholinergic signaling, but their functions and specificity have yet to be completely explored. We tested the selectivity and efficacy of leukocyte antigen, PLAUR (plasminogen activator, urokinase receptor) domain-containing (LYPD)-6B on ?3?4-, ?3?5?4-, and ?7-containing nicotinic acetylcholine receptors (nAChRs). To constrain stoichiometry, fusion proteins encoding concatemers of human ?3, ?4, and ?5 (D and N variants) subunits were expressed in Xenopus laevis oocytes and tested with or without LYPD6B. We used the 2-electrode voltage-clamp method to quantify responses to acetylcholine (ACh): agonist sensitivity (EC50), maximal agonist-induced current (Imax), and time constant (?) of desensitization. For ?4-?3-?3-?4-?3 and ?4-?3-?4-?3-?3, LYPD6B decreased EC50 from 631 to 79 ?M, reduced Imax by at least 59%, and decreased ?. For ?4-?3-?5D-?4-?3 and ?4-?3-?4-?-?5D, LYPD6B decreased Imax by 63 and 32%, respectively. Thus, LYPD6B acted only on (?3)3(?4)2 and (?3)2(?5D)(?4)2 and did not affect the properties of (?3)2(?4)3, ?7, or (?3)2(?5N)(?4)2 nAChRs. Therefore, LYPD6B acts as a mixed modulator that enhances the sensitivity of (?3)3(?4)2 nAChRs to ACh while reducing ACh-induced whole-cell currents. LYPD6B also negatively modulates ?3?4 nAChRs that include the ?5D common human variant, but not the N variant associated with nicotine dependence.
SUBMITTER: Ochoa V
PROVIDER: S-EPMC4750422 | biostudies-literature | 2016 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA